Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Chromadex Corp CS (CDXC)

Chromadex Corp CS (CDXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,686
  • Shares Outstanding, K 68,335
  • Annual Sales, $ 67,450 K
  • Annual Income, $ -27,130 K
  • 60-Month Beta 1.79
  • Price/Sales 1.94
  • Price/Cash Flow N/A
  • Price/Book 4.78
Trade CDXC with:

Options Overview Details

View History
  • Implied Volatility 131.08% ( +1.22%)
  • Historical Volatility 86.26%
  • IV Percentile 83%
  • IV Rank 30.48%
  • IV High 323.04% on 05/12/22
  • IV Low 46.93% on 12/23/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 71
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 6,061
  • Open Int (30-Day) 8,899

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.07
  • Number of Estimates 4
  • High Estimate -0.05
  • Low Estimate -0.09
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5100 +10.60%
on 05/13/22
2.1800 -23.39%
on 05/20/22
-0.3100 (-15.66%)
since 04/25/22
3-Month
1.5100 +10.60%
on 05/13/22
3.1600 -47.15%
on 03/02/22
-0.9500 (-36.26%)
since 02/25/22
52-Week
1.5100 +10.60%
on 05/13/22
10.7800 -84.51%
on 06/28/21
-6.1000 (-78.51%)
since 05/25/21

Most Recent Stories

More News
ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China

ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced it has entered into an agreement (the “JV Agreement”) to establish a joint...

CDXC : 1.6500 (-2.37%)
ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen®

ChromaDex Corp. (NASDAQ:CDXC) announced today that NutraIngredients , a leading news source for the nutrition industry, recently honored the ChromaDex External Research Program (CERP TM ) with a 2022...

CDXC : 1.6500 (-2.37%)
ChromaDex (CDXC) Reports Q1 Loss, Misses Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of -22.22% and 0.90%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 1.6500 (-2.37%)
BIOVF : 21.6850 (+8.42%)
ChromaDex Corporation Reports First Quarter 2022 Financial Results

ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2022.

CDXC : 1.6500 (-2.37%)
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of 52.63% and 55.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ADCT : 7.00 (-0.71%)
CDXC : 1.6500 (-2.37%)
Repare Therapeutics Inc. (RPTX) Reports Q1 Loss, Misses Revenue Estimates

Repare Therapeutics Inc. (RPTX) delivered earnings and revenue surprises of 6.74% and 80.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

RPTX : 8.90 (+0.68%)
CDXC : 1.6500 (-2.37%)
ChromaDex to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs. May 12, 2022 at 4:30 p.m. ET to discuss its financial results for the first quarter, which ended March 31, 2022. The...

CDXC : 1.6500 (-2.37%)
ChromaDex Appoints Ann Cohen and Kristin Patrick to its Board of Directors

ChromaDex Corp. (NASDAQ: CDXC) today announced that it has appointed two new members to its Board of Directors: Kristin Patrick, Executive Vice President and Chief Marketing Officer of Claire's Inc., and...

CDXC : 1.6500 (-2.37%)
ChromaDex External Research Program (CERP™) Celebrates Over 250 Research Agreements With 235+ Researchers Around the World

ChromaDex Corp. (NASDAQ:CDXC) today celebrates over 250 material transfer agreements (MTAs) through the ChromaDex External Research Program ( CERP ™), featuring ChromaDex’s flagship ingredient Niagen...

CDXC : 1.6500 (-2.37%)
ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product Portfolio

ChromaDex Corp. (NASDAQ:CDXC) today announced the company’s latest product innovation with the U.S. launch of Tru Niagen ® Immune , a first-of-its-kind combination of ChromaDex’s proprietary NAD-boosting...

CDXC : 1.6500 (-2.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is...

See More

Key Turning Points

3rd Resistance Point 1.9533
2nd Resistance Point 1.8967
1st Resistance Point 1.7933
Last Price 1.6500
1st Support Level 1.6333
2nd Support Level 1.5767
3rd Support Level 1.4733

See More

52-Week High 10.7800
Fibonacci 61.8% 7.2389
Fibonacci 50% 6.1450
Fibonacci 38.2% 5.0511
Last Price 1.6500
52-Week Low 1.5100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar